Chemed Statistics
Total Valuation
Chemed has a market cap or net worth of $6.31 billion. The enterprise value is $6.33 billion.
| Market Cap | 6.31B |
| Enterprise Value | 6.33B |
Important Dates
The last earnings date was Tuesday, October 28, 2025, after market close.
| Earnings Date | Oct 28, 2025 |
| Ex-Dividend Date | Nov 17, 2025 |
Share Statistics
Chemed has 14.11 million shares outstanding. The number of shares has decreased by -3.57% in one year.
| Current Share Class | 14.11M |
| Shares Outstanding | 14.11M |
| Shares Change (YoY) | -3.57% |
| Shares Change (QoQ) | -2.00% |
| Owned by Insiders (%) | 1.55% |
| Owned by Institutions (%) | 100.55% |
| Float | 13.88M |
Valuation Ratios
The trailing PE ratio is 23.62 and the forward PE ratio is 17.86. Chemed's PEG ratio is 2.04.
| PE Ratio | 23.62 |
| Forward PE | 17.86 |
| PS Ratio | 2.58 |
| Forward PS | 2.36 |
| PB Ratio | 5.86 |
| P/TBV Ratio | 19.44 |
| P/FCF Ratio | 17.52 |
| P/OCF Ratio | 15.05 |
| PEG Ratio | 2.04 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 15.35, with an EV/FCF ratio of 17.55.
| EV / Earnings | 22.69 |
| EV / Sales | 2.50 |
| EV / EBITDA | 15.35 |
| EV / EBIT | 17.97 |
| EV / FCF | 17.55 |
Financial Position
The company has a current ratio of 1.35, with a Debt / Equity ratio of 0.13.
| Current Ratio | 1.35 |
| Quick Ratio | 1.18 |
| Debt / Equity | 0.13 |
| Debt / EBITDA | 0.30 |
| Debt / FCF | 0.39 |
| Interest Coverage | 203.68 |
Financial Efficiency
Return on equity (ROE) is 24.11% and return on invested capital (ROIC) is 16.91%.
| Return on Equity (ROE) | 24.11% |
| Return on Assets (ROA) | 12.97% |
| Return on Invested Capital (ROIC) | 16.91% |
| Return on Capital Employed (ROCE) | 26.43% |
| Revenue Per Employee | $161,238 |
| Profits Per Employee | $17,764 |
| Employee Count | 15,695 |
| Asset Turnover | 1.49 |
| Inventory Turnover | 187.30 |
Taxes
In the past 12 months, Chemed has paid $91.65 million in taxes.
| Income Tax | 91.65M |
| Effective Tax Rate | 24.74% |
Stock Price Statistics
The stock price has decreased by -20.37% in the last 52 weeks. The beta is 0.46, so Chemed's price volatility has been lower than the market average.
| Beta (5Y) | 0.46 |
| 52-Week Price Change | -20.37% |
| 50-Day Moving Average | 445.00 |
| 200-Day Moving Average | 513.96 |
| Relative Strength Index (RSI) | 54.05 |
| Average Volume (20 Days) | 206,196 |
Short Selling Information
The latest short interest is 592,977, so 4.20% of the outstanding shares have been sold short.
| Short Interest | 592,977 |
| Short Previous Month | 387,671 |
| Short % of Shares Out | 4.20% |
| Short % of Float | 4.27% |
| Short Ratio (days to cover) | 3.03 |
Income Statement
In the last 12 months, Chemed had revenue of $2.53 billion and earned $278.81 million in profits. Earnings per share was $18.95.
| Revenue | 2.53B |
| Gross Profit | 832.13M |
| Operating Income | 351.95M |
| Pretax Income | 370.46M |
| Net Income | 278.81M |
| EBITDA | 412.00M |
| EBIT | 351.95M |
| Earnings Per Share (EPS) | $18.95 |
Balance Sheet
The company has $129.75 million in cash and $141.47 million in debt, giving a net cash position of -$11.72 million or -$0.83 per share.
| Cash & Cash Equivalents | 129.75M |
| Total Debt | 141.47M |
| Net Cash | -11.72M |
| Net Cash Per Share | -$0.83 |
| Equity (Book Value) | 1.08B |
| Book Value Per Share | 76.31 |
| Working Capital | 103.20M |
Cash Flow
In the last 12 months, operating cash flow was $419.65 million and capital expenditures -$59.21 million, giving a free cash flow of $360.44 million.
| Operating Cash Flow | 419.65M |
| Capital Expenditures | -59.21M |
| Free Cash Flow | 360.44M |
| FCF Per Share | $25.55 |
Margins
Gross margin is 32.88%, with operating and profit margins of 13.91% and 11.02%.
| Gross Margin | 32.88% |
| Operating Margin | 13.91% |
| Pretax Margin | 14.64% |
| Profit Margin | 11.02% |
| EBITDA Margin | 16.28% |
| EBIT Margin | 13.91% |
| FCF Margin | 14.24% |
Dividends & Yields
This stock pays an annual dividend of $2.40, which amounts to a dividend yield of 0.54%.
| Dividend Per Share | $2.40 |
| Dividend Yield | 0.54% |
| Dividend Growth (YoY) | 22.22% |
| Years of Dividend Growth | 16 |
| Payout Ratio | 11.61% |
| Buyback Yield | 3.57% |
| Shareholder Yield | 4.11% |
| Earnings Yield | 4.42% |
| FCF Yield | 5.71% |
Analyst Forecast
The average price target for Chemed is $574.25, which is 28.31% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $574.25 |
| Price Target Difference | 28.31% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 4 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on May 12, 2005. It was a forward split with a ratio of 2:1.
| Last Split Date | May 12, 2005 |
| Split Type | Forward |
| Split Ratio | 2:1 |
Scores
Chemed has an Altman Z-Score of 13.53 and a Piotroski F-Score of 5.
| Altman Z-Score | 13.53 |
| Piotroski F-Score | 5 |